Cumberland Pharmaceuticals Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CPIX research report →
About the company
Cumberland Pharmaceuticals Inc. functions as a specialized pharmaceutical enterprise, primarily involved in the procurement, advancement, and commercialization of prescription medications. Its strategic focus areas include acute hospital care, gastroenterology, rheumatology, and oncology, with operations spanning both the United States and global markets.
- CEO
- A. J. Kazimi
- IPO
- 2009
- Employees
- 91
- HQ
- Nashville, TN, US
Price Chart
- Market Cap
- $95.44M
- P/E
- -13.18
- P/S
- 2.28
- P/B
- 4.40
- EV/EBITDA
- -51.81
- Div Yield
- 0.00%
- Gross Margin
- 82.89%
- Op Margin
- -17.20%
- Net Margin
- -17.24%
- ROE
- -28.75%
- ROIC
- -19.50%
- Revenue
- $44.52M · 17.57%
- Net Income
- $-2,836,128 · 56.23%
- EPS
- $-0.19 · 58.70%
- Op Income
- $-2,791,993
- FCF YoY
- 710.51%
- 52W High
- $7.36
- 52W Low
- $1.85
- 50D MA
- $5.34
- 200D MA
- $3.85
- Beta
- 0.10
- Avg Volume
- 983.94K
Get TickerSpark's AI analysis on CPIX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | Brown Martin S JR | other | 1,800 |
| Mar 18, 26 | Galante Joseph C | other | 1,800 |
| Mar 18, 26 | Jones James | other | 1,800 |
| Mar 18, 26 | Krogulski Kenneth | other | 4,000 |
| Mar 18, 26 | Krogulski Kenneth | other | 1,800 |
| Mar 18, 26 | Young Caroline | other | 1,800 |
| Mar 18, 26 | Anthony Todd M. | other | 3,000 |
| Mar 18, 26 | Bitterman Chris T. | other | 3,000 |
| Mar 18, 26 | Hamm John M. | other | 3,000 |
| Mar 18, 26 | Herman James L | other | 2,500 |
Our CPIX coverage
Recent articles, reports, and earnings notes.
No research on CPIX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CPIX report →Similar companies
Peers in the same neighborhood.